We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Option for Restoring Hip Mobility

By HospiMedica staff writers
Posted on 02 Jul 2007
A new hip-bearing system recreates the natural ball and socket joint of the hip to help increase joint stability, range of motion, and longevity. More...


The Ultamet XL metal-on-metal modular bearing is used with the Pinnacle acetabular cup system, providing surgeons with the option of choosing a polyethylene or metal insert for use with the same outer titanium cup that replaces the socket of the natural hip. The bearings, available in both 28 and 36 mm articulation, are manufactured with a taper that allows the use of a 36 mm head and shells of 52 mm and larger. The new bearings offer greater range of motion and stability, with up to 159° range of motion and 20 mm of jump distance; 99.9% survivorship at five years; and significant wear reduction.

By maximizing the size of the femoral head relative to the outer diameter of the acetabular shell, the Ultamet XL bearings allow for enhanced stability while preserving acetabular bone. Both the Ultamet XL and the Pinnacle acetabular cup system are products of DePuy Orthopaedics (Warsaw, IN, USA), a Johnson & Johnson (New Brunswick, NJ, USA) company.

"The Pinnacle cup exhibited 99.9% survivorship at five years,” said William P. Barrett, M.D., from Valley Orthopaedic Associates/Proliance Surgeons (Renton, WA, USA). "And, significantly, differences between patients, surgeons, femoral stems, head size, and articulation types did not affect survival.”


Related Links:
DePuy Orthopaedics
Johnson & Johnson

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.